Interventional Oncology Market Analysis and Forecast to 2025 by Key Players BTG plc , Medtronic, Boston Scientific, Terumo, Merit Medical, Sirtex, AngioDynamics, Ethicon, Teleflex , Cook Medical, HealthTronics, MedWaves Medical, Sanarus, IMBiotechnologies

Global Interventional Oncology Industry was valued at USD 2 Billion in the year 2019. Global Interventional Oncology Industry is further estimated to grow at a CAGR of 7.5% from 2019 to reach USD 3.28 Billion by the year 2025.

Get Free Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-GRS-HnM-239511

Major market players in Interventional Oncology Industry are BTG plc , Medtronic, Boston Scientific, Terumo, Merit Medical, Sirtex, AngioDynamics, Ethicon, Teleflex , Cook Medical, HealthTronics, MedWaves Medical, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical, Shape Memory Medical, Endo Shape, Monteris Medical, Instylla, and Trisalus Lifesciences.

The development of this market is principally determined by the rising inclination for negligibly intrusive techniques, extension of the objective patient populace, expanding open private subsidizing and government support for disease inquire about, mechanical progressions in the field of interventional oncology, and expanding government ventures and funding for interventional oncology and related cancer research.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-GRS-HnM-239511

The increasing demand for minimally invasive MI procedures is driving the growth of the global interventional oncology industry. The increasing awareness about the benefits of MI surgeries, such as reduced risk of shorter hospital stay, infection, minimal complications, lesser pain, and a faster recovery time when compared to the conventional open surgeries, are encouraging patients and surgeons to opt for MI surgeries, resulting in the high growth of this industry. The global interventional oncology industry will continue to be driven by these factors over the coming years.

The increasing demand of image-guided solutions in interventional oncology industry procedures, thanks to the improvement of these solutions provide in the treatment and diagnosis of cancer-related issues, is also expected to supplement the growth prospects of this industry in the near future.

In the presence of a number of local and international vendors characterizes the business landscape of the global industry for interventional oncology, which is highly competitive and diversified. Technological advancements and constant introduction of new products are likely to intensify the competitive environment in the industry. The leading market players are focusing on expanding their product portfolios.

Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-GRS-HnM-239511/ (Priced at USD 2999)

Interventional Oncology Industry Segmentation:
Interventional Oncology Industry Overview, By Procedure
• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization
• Transcatheter Arterial Embolization

Interventional Oncology Industry Overview, By Cancer Type
• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers

Interventional Oncology Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
IN +919881074592
info@qurateresearch.com
https://www.qurateresearch.com/

This release was published on openPR.